Urogen Pharma's total assets for Q1 2026 were $253.69M, an increase of 26.56% from the previous quarter. URGN total liabilities were $377.94M for the fiscal quarter, a 23.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.